Naperville, IL -- (SBWIRE) -- 08/08/2014 -- Reportstack, provider of premium market research reports announces the addition of Global Heart Defect Closure Devices Market 2014-2018 market report to its offering
About Heart Defect Closure Devices
Heart defect closure devices are used for the treatment of several CHDs. The heart closure devices help when closing the ostium/ hole/ deficiency in the structure of the heart present in the septal walls or blood vessels that occurs in the patients with CHDs. CHD is an anomaly in the structure of the heart present at the time of birth, which are among the most common types of birth defects. Some of the CHDs include ASD, PFO, VSD, PDA and LAA. These defects cause disruption of the normal flow of blood through the heart. CHDs can happen because of incomplete or abnormal development of the heart of the fetus in the womb during the very early weeks of pregnancy.
Analysts forecast the Global Heart Defect Closure Devices market will grow at a CAGR of 9 percent over the period 2013-2018.
Covered in this Report
The Global Heart Defect Closure Devices market can be categorized into segments on the basis of heart defects: Atrial Septal Defect, Left Atrial Appendage, Patent Foramen Ovale, Patent Ductus Arteriosus, and Ventricular Septal Defect. Global Heart Defect Closure Devices Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Heart Defect Closure Devices market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
Americas
EMEA
APAC
Key Vendors
Boston Scientific Corp.
St. Jude Medical Inc.
W.L. Gore and Associates Inc.
Other Prominent Vendors
Biosense Webster
Cardia Inc.
LifeTech Scientific
Maquet Cardiovascular
Medtronic
Occlutech Holding AG
Pfm medical
Starway Medical Technology
Terumo Cardiovascular
Key Market Driver
Increase in Incidence of CHDs.
For a full, detailed list, view our report.
Key Market Challenge
Potential Risk of Complications.
For a full, detailed list, view our report.
Key Market Trend
Emerging Use of LAA Closure Devices for Stroke Prevention.
For a full, detailed list, view our report.
Key Questions Answered in this Report
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Companies Mentioned
Boston Scientific Corp., St. Jude Medical Inc., W.L. Gore and Associates Inc.Other Prominent Vendors, Biosense Webster, Cardia Inc. , LifeTech Scientific , Maquet Cardiovascular, Medtronic , Occlutech Holding AG, Pfm medical, Starway Medical Technology ,Terumo Cardiovascula
To view the table of contents for this market research report please visit
http://www.reportstack.com/product/166177/global-heart-defect-closure-devices-market-2014-2018.html
Contact:
Roger Campbell
contactus@reportstack.com
Naperville
Illinois
United States
Ph: 888-789-6604